TGEN-LED STUDY RESULTS SUGGEST A MORE ACCURATE DIAGNOSTIC FOR BREAST CANCER
Proteomics-based technology could help verify mammography screening
PHOENIX, Ariz. — Jan. 26, 2021 — Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Written by